FDA Approves Semaglutide (Ozempic) for Kidney Protection in Diabetes Patients with CKD
A breakthrough in diabetes and kidney care! The FDA has approved Semaglutide (Ozempic) to help reduce the risk of worsening kidney disease, kidney failure, and cardiovascular-related deaths in adults with type 2 diabetes and chronic kidney disease (CKD). This makes Ozempic the first and only GLP-1 receptor agonist approved for this indication. Why This Approval […]







